UBS Group’s Lux Health Tech Acquisition Corp. Warrants LUXAW Stock Holding History

UBS Group’s Portfolio LUXAW Stock Details LUXAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-8,558	Closed	-$1K	–	11894
2022 Q3	$1K	Buy	8,558 +4,900	+134%	+$694	﹤0.01%	10240
2022 Q2	$1K	Sell	3,658 -5,000	-58%	-$1.26K	﹤0.01%	10180
2022 Q1	$4K	Buy	8,658 +1,160	+15%	+$659	﹤0.01%	9401
2021 Q4	$7K	Buy	+7,498	New	+$8.24K	﹤0.01%	9220

UBS Group's LUXAW Position: Q4 2022 in Review

UBS Group sold out of Lux Health Tech Acquisition Corp. Warrants (LUXAW) in Q4 2022, closing a stake of 8,558 shares — an estimated $1K sold.

UBS Group first reported a position in LUXAW in Q4 2021 and held it in 4 quarters. The position peaked at $7K in Q4 2021. 0 funds tracked by Wall St. Rank hold LUXAW as of Q4 2022.

UBS Group reported no remaining Lux Health Tech Acquisition Corp. Warrants position as of Q4 2022 after selling out during the quarter.
UBS Group sold 8,558 Lux Health Tech Acquisition Corp. Warrants shares in Q4 2022, an estimated $1K.
UBS Group first reported a position in Lux Health Tech Acquisition Corp. Warrants in Q4 2021 and held it in 4 quarters.
UBS Group's Lux Health Tech Acquisition Corp. Warrants position peaked at $7K in Q4 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Warrants as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.